Czech generics company Zentiva Group has begun bulking up on acquisitions and says it is on the lookout for more opportunities as it seeks to become “the champion of generics in Europe” under its new owner, private-equity giant Advent International.
Zentiva, which has a strong presence in Eastern Europe, particularly in the Czech Republic, Slovakia and Romania, announced it is...





